Harmon, Linder & Rogowsky Reviews Statins and Their Use by Healthy People

 

Heart disease is the leading cause of death in the United States. Each year, an estimated 610,000 people will die from heart disease. That roughly accounts for one in every four deaths. Many more people have high blood pressure, high cholesterol, and other health issues that could trigger a heart attack or other cardiac event. If you could prevent this from happening, most would agree that would be a good thing. However, is there too much of a good thing?

 

There’s no question that statins have saved lives. Statins lower cholesterol by reducing the amount of bad cholesterol produced by the liver. They also reduce the number of triglycerides in the blood and improve good cholesterol level as well. For people who have significant heart disease or have specific risk factors, they can be highly effective. They are used to lower the risk of stroke, heart attack, and other heart complications in people with diabetes and coronary heart disease

 

However, the FDA has approved statin use as a means for prevention, which is where things get a little hairy. According to information on the website of  Harmon, Linder & Rogoswky,  the benefits may not outweigh the risks for healthy people who use statins as prevention. Harmon, Linder & Rogowsky reviews the latest medical literature to determine whether or not clients have a case against pharmaceutical companies and others for product liability.

 

They also note that statins could raise a person’s risk of developing Type 2 diabetes by 9 percent and question whether or not the blood testing for statin candidates is accurate and shows cardiovascular issues. Finally, the law firm and many medical experts have raised concerns about the powerful statin Crestor as it has been shown to increase the rate of kidney damage in patients using the medication by 75 times higher than in patients taking other cholesterol drugs.

 

Leave a Reply

Your email address will not be published. Required fields are marked *